OBJECTIVE: Intratumoral arteriovenous shunting in glioblastomas has been suspected but neither proven nor quantified. METHODS: Using a previously described technique of selective intra-arterial intratumoral injection of 99mTc-labeled microparticles (macroaggregated albumin), we measured the amount of radioactivity, by cerebral and pulmonary scintigraphy, in seven patients with malignant gliomas (six with glioblastomas and one with an anaplastic oligodendroglioma). The pulmonary shunt index was calculated as a percentage from the pulmonary/pulmonary plus cerebral radioactivity ratio. RESULTS: The results revealed a mean pulmonary shunt index of 67% (range, 47-89%), indicating that most of the microparticles injected into the tumor via the arterial route bypassed the tumor and reached the lungs. The measured arteriovenous shunting was greater when the injection was performed in an artery exclusively perfusing the tumor. CONCLUSION: Important intratumoral arteriovenous shunting exists in glioblastomas. The potential consequences of this finding for intra-arterial treatment strategies are discussed.
OBJECTIVE: Intratumoral arteriovenous shunting in glioblastomas has been suspected but neither proven nor quantified. METHODS: Using a previously described technique of selective intra-arterial intratumoral injection of 99mTc-labeled microparticles (macroaggregated albumin), we measured the amount of radioactivity, by cerebral and pulmonary scintigraphy, in seven patients with malignant gliomas (six with glioblastomas and one with an anaplastic oligodendroglioma). The pulmonary shunt index was calculated as a percentage from the pulmonary/pulmonary plus cerebral radioactivity ratio. RESULTS: The results revealed a mean pulmonary shunt index of 67% (range, 47-89%), indicating that most of the microparticles injected into the tumor via the arterial route bypassed the tumor and reached the lungs. The measured arteriovenous shunting was greater when the injection was performed in an artery exclusively perfusing the tumor. CONCLUSION: Important intratumoral arteriovenous shunting exists in glioblastomas. The potential consequences of this finding for intra-arterial treatment strategies are discussed.
Authors: Daniel Lewis; Xiaoping Zhu; David J Coope; Sha Zhao; Andrew T King; Timothy Cootes; Alan Jackson; Ka-Loh Li Journal: Sci Rep Date: 2022-05-24 Impact factor: 4.996
Authors: Peter S LaViolette; Alex D Cohen; Melissa A Prah; Scott D Rand; Jennifer Connelly; Mark G Malkin; Wade M Mueller; Kathleen M Schmainda Journal: Neuro Oncol Date: 2013-02-03 Impact factor: 12.300
Authors: Elizabeth R Gerstner; Zheng Zhang; James R Fink; Mark Muzi; Lucy Hanna; Erin Greco; Melissa Prah; Kathleen M Schmainda; Akiva Mintz; Lale Kostakoglu; Edward A Eikman; Benjamin M Ellingson; Eva-Maria Ratai; A Gregory Sorensen; Daniel P Barboriak; David A Mankoff Journal: Clin Cancer Res Date: 2016-05-16 Impact factor: 12.531
Authors: S Ali Nabavizadeh; Hamed Akbari; Jeffrey B Ware; MacLean Nasrallah; Samantha Guiry; Stephen J Bagley; Arati Desai; Scott Levy; Whitney Sarchiapone; Timothy Prior; John Detre; Ronald L Wolf; Donald M O'Rourke; Steven Brem; Christos Davatzikos Journal: Sci Rep Date: 2019-06-19 Impact factor: 4.379
Authors: Arjun Khanna; Andrew S Venteicher; Brian P Walcott; Kristopher T Kahle; Daniel A Mordes; Christopher M William; Zoher Ghogawala; Christopher S Ogilvy Journal: Front Neurol Date: 2013-09-30 Impact factor: 4.003